Company: RVRC
Filing Date: 2025-08-13
Form Type: S-1/A
Source: 0001213900-25-075747
Chunk: 66

Company: Revium Rx.
Filing Date: 2025-08-13
Form: S-1/A
Chunk 66
---
2024, the Predecessor period from January 1, 2024 through
July 23, 2024, and for the year ended December 31, 2023.

|                             |     | Successor    
 through      
 December 31, 
 2024         |        For 
        the 
     period 
 commencing 
    July 24 |   |     | Predecessor 
 through     
 July 23,    
 2024        |               For 
               the 
 period commencing 
         January 1 |     | year         
 ended        
 December 31, 
 2023         | For the |   |
|:----------------------------|:----|:-------------|-----------:|:--|:----|:------------|------------------:|:----|:-------------|--------:|:--|
| Operating expenses          |     |              |            |   |     |             |                   |     |              |         |   |
| Research and                
 development expenses        |     |              |        996 |   |     |             |             1,162 |     |              |     846 |   |
| General                     
 and administrative expenses |     |              |      1,153 |   |     |             |               257 |     |              |     156 |   |
| Operating                   
 loss                        |     |              |      2,149 |   |     |             |             1,419 |     |              |   1,002 |   |
| Financial                   
 income, net                 |     |              |        (65 | ) |     |             |                 2 |     |              |     (15 | ) |
| Net                         
 loss and comprehensive loss |     |              |      2,084 |   |     |             |             1,421 |     |              |     987 |   |

| *) | less than 1 thousand |

We have prepared our discussion of the results
of operations by comparing the results of the combined Successor period from July 24, 2024 through December 31, 2024 and from January
1, 2024 through July 23, 2024 the Predecessor period for the years ended December 31, 2023 and December 31, 2022.

We believe this approach provides the most meaningful
basis of comparison and is more useful in identifying current business trends for the periods presented. The combined results of operations
included in our discussion